Видео ютуба по тегу Icml 2017 Follicular Lymphoma

Prof. Nathan Fowler | ASH 2017 | Highlights of ASH 2017 in Follicular Lymphoma
Prof. Nathan Fowler | ASH 2017 | Highlights of ASH 2017 in Follicular Lymphoma
Prof. Gilles Salles | ASH 2017 | Rituximab maintenance in follicular lymphoma
Prof. Gilles Salles | ASH 2017 | Rituximab maintenance in follicular lymphoma
Overview of classical therapies for follicular lymphoma
Overview of classical therapies for follicular lymphoma
Clinicogenetic risk models to predict outcome of follicular lymphoma patients
Clinicogenetic risk models to predict outcome of follicular lymphoma patients
The value of the ICML and highlights from the 2017 Annual Congress
The value of the ICML and highlights from the 2017 Annual Congress
Key therapeutic advances in follicular lymphoma
Key therapeutic advances in follicular lymphoma
Using models to predict progression in follicular lymphoma
Using models to predict progression in follicular lymphoma
Immunotherapy highlights from ICML 2017
Immunotherapy highlights from ICML 2017
Copanlisib produces promising results in relapsed/refractory follicular lymphoma
Copanlisib produces promising results in relapsed/refractory follicular lymphoma
Highlights from ICML 2017: The CLL2-BAG study
Highlights from ICML 2017: The CLL2-BAG study
ICML 2017 session on the biosimilar rituximab: challenges and data
ICML 2017 session on the biosimilar rituximab: challenges and data
Top follicular lymphoma discussion points at ICML 2017
Top follicular lymphoma discussion points at ICML 2017
Dr. Michael Dickinson: Tazemetostat in FL and DLBCL – ICML 2017
Dr. Michael Dickinson: Tazemetostat in FL and DLBCL – ICML 2017
Promising CLL & FL data from ICML 2017: BGB-3111 and obinituzumab
Promising CLL & FL data from ICML 2017: BGB-3111 and obinituzumab
Prof. Marek Trněný: Update on the GOYA study – ICML 2017
Prof. Marek Trněný: Update on the GOYA study – ICML 2017
The latest data in diffuse large B-cell lymphoma from ICML 2017
The latest data in diffuse large B-cell lymphoma from ICML 2017
Prof. Andrés Ferreri: Extranodal MZL and the use of clarithromycin – ICML 2017
Prof. Andrés Ferreri: Extranodal MZL and the use of clarithromycin – ICML 2017
Prof. Sonali Smith: Highlights of educational sessions on Aggressive Lymphoma - ICML 2017
Prof. Sonali Smith: Highlights of educational sessions on Aggressive Lymphoma - ICML 2017
The combination of BGB-3111 and obinutuzumab for follicular lymphoma: promising preliminary results
The combination of BGB-3111 and obinutuzumab for follicular lymphoma: promising preliminary results
Prof. Anas Younes: Genome sequencing data in clinical practice - ICML 2017
Prof. Anas Younes: Genome sequencing data in clinical practice - ICML 2017